Patent · US Active

Glycopeptide and uses thereof

US9446144B2 · kind B2 · utility

1Cited by

15References

10Claims

0Family size

Assignee

University of Georgia Research Foundation, Inc. · US

Inventors

Geert-Jan Boons · Athens, US
Therese Buskas · Athens, US
Sampat Ingale · San Diego, US
Margaretha Wolfert · Athens, US

Key dates

Filing date	Dec 31, 2013
Grant date	Sep 20, 2016
Priority date	—
Expiry date	Dec 31, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/2821
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A glycolipopeptide comprising a carbohydrate component, a peptide component and a lipid component, for use as a therapeutic or prophylactic vaccine. Also provided are monoclonal and polyclonal antibodies that recognize the glycolipopeptide of the invention, as well as uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.